On the other hand, mutant BRAF (V600E) has been reported to constitutively phosphorylate ERK which can phosphorylate LKB1 directly or indirectly through ribosomal S6 kinase (RSK), and subsequently suppress LKB1 capability to activate AMPK in melanomas [23, 24]. The gene discussed is BRAF; the disease is melanoma.